Talaris Therapeutics (TALS) director Ildstad sold 29 shares for $59.45 at $2.05

Insider transactions reported

Suzanne Ildstad (director at Talaris Therapeutics Inc., TALS) reported that they sold 29 shares for $59.45 at $2.05 on Mar 1, 2023. After these transactions the filing shows 3,071,366 shares held directly.

Reporting person

Ildstad Suzanne

Holdings before and after

• Common Stock: 3,071,395 to 3,071,366 direct

Other positions listed

• Common Stock: 1,200,000 indirect, by GRAT
• Common Stock: 654,205 indirect, See footnote
• Common Stock: 654,205 indirect, See footnote

Footnotes from the filing

1. 1. These shares are held in a trust for the benefit of the Reporting Person's son. The Reporting Person's son is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. 2. These shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's daughter is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Transaction codes in this filing

Open-market sale:

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

FAQ